CSIMarket
 
Alterity Therapeutics Limited  (NASDAQ: ATHE)
 

Alterity Therapeutics Limited's Suppliers Performance

ATHE's Supply Chain




 
ATHE Costs vs Sales of Suppliers Growth

• More on ATHE Suppliers






Alterity Therapeutics Limited's Comment on Supply Chain


The company depends on a limited number of third-party contract manufacturers for producing its product candidates. These manufacturers are required to comply with Good Manufacturing Practice (GMP) regulations as mandated by the FDA, ICH, European, and other regulatory authorities. The company faces challenges related to scale-up, optimization, formulation, volume production, and quality control. Contract manufacturers may experience personnel shortages and must successfully pass regulatory inspections. Changing manufacturers involves costly and time-consuming re-validation processes. Additionally, the company currently lacks experience in marketing, sales, and distribution and may need to collaborate with other parties for these functions, which carries risks related to commercialization success.

Alterity Therapeutics Limited's Comment on Supply Chain


The company depends on a limited number of third-party contract manufacturers for producing its product candidates. These manufacturers are required to comply with Good Manufacturing Practice (GMP) regulations as mandated by the FDA, ICH, European, and other regulatory authorities. The company faces challenges related to scale-up, optimization, formulation, volume production, and quality control. Contract manufacturers may experience personnel shortages and must successfully pass regulatory inspections. Changing manufacturers involves costly and time-consuming re-validation processes. Additionally, the company currently lacks experience in marketing, sales, and distribution and may need to collaborate with other parties for these functions, which carries risks related to commercialization success.







ATHE's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Alterity Therapeutics Limited 2,347.67 0.00 -12.15 11
SUBTOTAL 0.00 0.00 0.00 -


Sources: Alterity Therapeutics Limited's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Alterity Therapeutics Limited’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.